Biochemical Insights into a Novel Family 2 Glycoside Hydrolase with Both -1,3-Galactosidase and -1,4-Galactosidase Activity from the Arctic

Dianyi Li,Zheng Wang,Yong Yu,Huirong Li,Wei Luo,Bo Chen,Guoqing Niu,Haitao Ding
DOI: https://doi.org/10.3390/md21100521
2023-01-01
Marine Drugs
Abstract:A novel GH2 (glycoside hydrolase family 2) beta-galactosidase from Marinomonas sp. BSi20584 was successfully expressed in E. coli with a stable soluble form. The recombinant enzyme (rMaBGA) was purified to electrophoretic homogeneity and characterized extensively. The specific activity of purified rMaBGA was determined as 96.827 U mg(-1) at 30 degrees C using ONPG (o-nitrophenyl-beta-D-galactopyranoside) as a substrate. The optimum pH and temperature of rMaBGA was measured as 7.0 and 50 degrees C, respectively. The activity of rMaBGA was significantly enhanced by some divalent cations including Zn2+, Mg2+ and Ni2+, but inhibited by EDTA, suggesting that some divalent cations might play important roles in the catalytic process of rMaBGA. Although the enzyme was derived from a cold-adapted strain, it still showed considerable stability against various physical and chemical elements. Moreover, rMaBGA exhibited activity both toward Gal beta-(1,3)-GlcNAc and Gal beta-(1,4)-GlcNAc, which is a relatively rare occurrence in GH2 beta-galactosidase. The results showed that two domains in the C-terminal region might be contributed to the beta-1,3-galactosidase activity of rMaBGA. On account of its fine features, this enzyme is a promising candidate for the industrial application of beta-galactosidase.
What problem does this paper attempt to address?